Search

Your search keyword '"Koning, René"' showing total 165 results

Search Constraints

Start Over You searched for: Author "Koning, René" Remove constraint Author: "Koning, René"
165 results on '"Koning, René"'

Search Results

1. Prevalence and location of coronary artery disease in anomalous aortic origin of coronary arteries

2. The France PCI registry: Design, methodology and key findings

3. Safety and efficacy of the latest generation biodegradable polymer-coated ultrathin sirolimus-eluting stent in the treatment of coronary artery disease in a European all-comer population with or without high bleeding risk: The Cruz HBR Registry

4. Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease

5. Safety and efficacy of the latest generation biodegradable polymer-coated ultrathin sirolimuseluting stent in the treatment of coronary artery disease in a European all-comer population with or without high bleeding risk: The Cruz HBR Registry.

6. DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCI

9. In-Hospital and 1-Year Clinical Results from the French Registry Using Polymer-Free Sirolimus-Eluting Stents in Acute Coronary Syndrome and Stable Coronary Artery Disease

10. Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve Replacement

11. The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial

13. Association of the PHACTR1/EDN1 Genetic Locus With Spontaneous Coronary Artery Dissection

16. Impact of Direct Transcatheter Aortic Valve Replacement Without Balloon Aortic Valvuloplasty on Procedural and Clinical Outcomes: Insights From the FRANCE TAVI Registry

17. Impact of technique on bifurcation stent outcomes in the European Bifurcation Club Left Main Coronary Trial

18. Impact of technique on bifurcation stent outcomes in the European Bifurcation Club Left Main Coronary Trial

19. Five-year clinical outcomes using the bioresorbable vascular scaffold: Insights from the FRANCE ABSORB registry

22. Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial

23. Indirect Transfer to Catheterization Laboratory for ST Elevation Myocardial Infarction Is Associated With Mortality Independent of System Delays: Insights From the France-PCI Registry

24. Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice – results from the European Absorb Consortium

25. Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease

26. Effectiveness of Mangroves in Flood Risk Reduction

29. Analysis of length of stay after transfemoral transcatheter aortic valve replacement: results from the FRANCE TAVI registry

30. Impact of Direct TAVR Without Balloon Aortic Valvuloplasty on Procedural and Clinical Outcomes Insights From the FRANCE TAVI Registry

31. Carotid versus femoral access for transcatheter aortic valve implantation: a propensity score inverse probability weighting study

32. Analysis of Length of Hospital Stay after Transfemoral Transcatheter Aortic Valve Implantation: Results from the FRANCE TAVI (FRench Transcatheter Aortic Valve Implantation) Registry

33. Association of the PHACTR1/EDN1 Genetic Locus With Spontaneous Coronary Artery Dissection

34. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

35. PoDeA, Port development Argentina

37. Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI

38. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

39. Comparison of Immediate With Delayed Stenting Using the Minimalist Immediate Mechanical Intervention Approach in Acute ST-Segment-Elevation Myocardial Infarction: The MIMI Study

40. France: coronary and structural heart interventions from 2010 to 2015

41. De FRANCE 2 à FRANCE TAVI : les indications, la technique et les résultats du remplacement valvulaire aortique percutané sont-ils les mêmes ?

43. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vsaspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

45. Early and long-term results of unprotected left main coronary artery stenosis with paclitaxel-eluting stents: the FRIEND (French multicentre registry for stenting of unprotected LMCA stenosis) registry

46. Drug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients.

Catalog

Books, media, physical & digital resources